Nakamoto Inc 's Cash & cash equivalent grew by 1.82 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Nakamoto Inc 's Quick Ratio to 0.15, Quick Ratio remained below Nakamoto Inc average.

Within Medical Equipment & Supplies industry 183 other companies have achieved higher Quick Ratio than Nakamoto Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3013 to 3675.

Explain Quick Ratio?
How much Cash & cash equivalents NAKA�s has?
What are NAKA�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NAKA/financial-strength

https://api.csimarket.com/api/v1/companies/NAKA/fundamentals

https://api.csimarket.com/api/v1/companies/NAKA/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

NAKA Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-40.58 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-19.7 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.15	Subscribe	Subscribe	Subscribe	Subscribe
NAKA's Total Ranking	# 3675	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-29 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	1.82 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 184
Healthcare Sector	# 849
Overall Market	# 3675

Quick Ratio Statistics
High	Average	Low
12.32	2.71	0.1
(Jun 30 2025)		(Dec 31 2025)

Financial Statements
Nakamoto Inc 's Current Liabilities	$ 127 Millions	Visit NAKA's Balance sheet
Nakamoto Inc 's Cash & cash equivalent	$ 19 Millions	Visit NAKA's Balance sheet
Source of NAKA's Sales		Visit NAKA's Sales by Geography

Cumulative Nakamoto Inc 's Quick Ratio

NAKA's Quick Ratio for the trailling 12 Months

NAKA Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	247.33 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	181.65 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.13	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4191	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-10.39 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-4.78 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to NAKA Financial Strength Comparisons >> Go to Compare NAKA Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Nakamoto Inc 's average Cash & cash equivalent, this led to increase in in Nakamoto Inc 's Quick Ratio to 0.13, Quick Ratio remained below NAKA average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 207 other companies have achieved higher Quick Ratio than Nakamoto Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3017 to 4191.

Explain Quick Ratio?
How much Cash & cash equivalents NAKA�s has?
What are NAKA�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 208
Healthcare Sector	# 920
Within the Market	# 4191

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.51	1.96	0.12
(Jun 30 2025)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Sanuwave Health Inc	0.40	$ 6.569 Millions	$ 16.394 Millions
Novocure Limited	0.38	$ 102.738 Millions	$ 270.659 Millions
Plus Therapeutics Inc	0.37	$ 4.871 Millions	$ 13.123 Millions
Cadre Holdings inc	0.36	$ 63.916 Millions	$ 178.051 Millions
U S Physical Therapy Inc	0.35	$ 38.225 Millions	$ 109.218 Millions
Tela Bio Inc	0.31	$ 22.664 Millions	$ 73.706 Millions
Nexalin Technology Inc	0.29	$ 0.793 Millions	$ 2.761 Millions
Tandem Diabetes Care Inc	0.28	$ 72.840 Millions	$ 256.075 Millions
Ufp Technologies Inc	0.27	$ 20.625 Millions	$ 77.359 Millions
Docgo Inc	0.26	$ 20.569 Millions	$ 79.655 Millions
Bausch and Lomb Corp	0.25	$ 513.000 Millions	$ 2,019.000 Millions
Accuray Incorporated	0.25	$ 42.254 Millions	$ 170.106 Millions
Cerus Corporation	0.20	$ 16.350 Millions	$ 80.006 Millions
Bioventus Inc	0.19	$ 30.709 Millions	$ 159.282 Millions
Nakamoto Inc	0.15	$ 19.420 Millions	$ 127.428 Millions
Dentsply Sirona Inc	0.15	$ 195.000 Millions	$ 1,312.000 Millions
National Vision Holdings Inc	0.15	$ 59.963 Millions	$ 405.705 Millions
Boston Scientific Corporation	0.13	$ 904.000 Millions	$ 7,150.000 Millions
Solventum Corporation	0.13	$ 451.000 Millions	$ 3,575.000 Millions
The Pennant Group Inc	0.12	$ 18.389 Millions	$ 151.730 Millions
Zimmer Biomet Holdings Inc	0.11	$ 399.900 Millions	$ 3,502.400 Millions
Bellevue Life Sciences Acquisition Corp	0.08	$ 1.368 Millions	$ 16.679 Millions
Integer Holdings Corporation	0.07	$ 14.135 Millions	$ 201.125 Millions
Solana Company	0.07	$ 1.129 Millions	$ 16.615 Millions
Vycor Medical Inc	0.04	$ 0.199 Millions	$ 5.107 Millions
Nuo Therapeutics Inc	0.03	$ 0.081 Millions	$ 2.455 Millions

Date modified: 2026-11-13T21:26:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.